{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:45:03Z","timestamp":1786538703598,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,10]],"date-time":"2026-12-10T00:00:00Z","timestamp":1796860800000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJFR2022"],"award-info":[{"award-number":["JPMJFR2022"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22 K07267"],"award-info":[{"award-number":["22 K07267"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19 K09488"],"award-info":[{"award-number":["19 K09488"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21 K09105"],"award-info":[{"award-number":["21 K09105"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20ck0106567s0201"],"award-info":[{"award-number":["20ck0106567s0201"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22 K09210"],"award-info":[{"award-number":["22 K09210"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18 K16592"],"award-info":[{"award-number":["18 K16592"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.radonc.2025.111325","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T23:02:26Z","timestamp":1765148546000},"page":"111325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Local therapy with hypoxia-targeting radiopharmaceutical [64Cu]Cu-ATSM in high-grade glioma patient-derived xenograft models"],"prefix":"10.1016","volume":"214","author":[{"given":"Yukie","family":"Yoshii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukiko","family":"Hihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4044-0281","authenticated-orcid":false,"given":"Hiroki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Shinada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ohtake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kaneta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemitsu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiteru","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Wakimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ukihide","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9977-9373","authenticated-orcid":false,"given":"Tetsuya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6895-9013","authenticated-orcid":false,"given":"Kensuke","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111325_b0005","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2025.111325_b0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111325_b0015","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/neuonc\/now258","article-title":"Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells","volume":"19","author":"Colwell","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2025.111325_b0020","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41419-022-05389-1","article-title":"PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism","volume":"13","author":"Liao","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.radonc.2025.111325_b0025","first-page":"1155","article-title":"Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential","volume":"38","author":"Fujibayashi","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2025.111325_b0030","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1073\/pnas.98.3.1206","article-title":"Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): an agent for radiotherapy","volume":"98","author":"Lewis","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.radonc.2025.111325_b0035","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/BF02988502","article-title":"Retention mechanism of hypoxia selective nuclear imaging\/radiotherapeutic agent cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells","volume":"15","author":"Obata","year":"2001","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.radonc.2025.111325_b0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nucmedbio.2004.08.012","article-title":"Basic characterization of 64Cu-ATSM as a radiotherapy agent","volume":"32","author":"Obata","year":"2005","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.radonc.2025.111325_b0045","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13550-019-0586-6","article-title":"(64)Cu-ATSM\/(64)Cu-Cl(2) and their relationship to hypoxia in glioblastoma: a preclinical study","volume":"9","author":"Peres","year":"2019","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.radonc.2025.111325_b0050","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1088\/0031-9155\/54\/7\/017","article-title":"In vitro kinetic studies on the mechanism of oxygen-dependent cellular uptake of copper radiopharmaceuticals","volume":"54","author":"Holland","year":"2009","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2025.111325_b0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nucmedbio.2011.08.008","article-title":"Radiolabeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less rho0 cells and cybrids carrying MELAS mitochondrial DNA mutation","volume":"39","author":"Yoshii","year":"2012","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.radonc.2025.111325_b0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3174\/ajnr.A3159","article-title":"Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1alpha expression in patients with glioma","volume":"34","author":"Tateishi","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.radonc.2025.111325_b0065","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3174\/ajnr.A3679","article-title":"(62)Cu-diacetyl-bis (N(4)-methylthiosemicarbazone) PET in human gliomas: comparative study with [(18)F]fluorodeoxyglucose and L-methyl-[(11)C]methionine PET","volume":"35","author":"Tateishi","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.radonc.2025.111325_b0070","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/786463","article-title":"The copper radioisotopes: a systematic review with special interest to 64Cu","volume":"2014","author":"Niccoli Asabella","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.radonc.2025.111325_b0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.nucmedbio.2010.08.009","article-title":"Internal radiotherapy with copper-64-diacetyl-bis (N(4)-methylthiosemicarbazone) reduces CD133(+) highly tumorigenic cells and metastatic ability of mouse colon carcinoma","volume":"38","author":"Yoshii","year":"2011","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.radonc.2025.111325_b0080","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/jrr\/rrv042","article-title":"Validation of 64Cu-ATSM damaging DNA via high-LET Auger electron emission","volume":"56","author":"McMillan","year":"2015","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2025.111325_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12103022","article-title":"Carbon Ion radiobiology","volume":"12","author":"Tinganelli","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2025.111325_b0090","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/jjco\/hyaf026","article-title":"Efficacy of radioactive hypoxia-targeting therapeutic agent 64Cu-ATSM on recurrent malignant glioma: a study protocol for a phase-III, investigator-sponsored, randomized controlled trial","volume":"55","author":"Ando","year":"2025","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111325_b0095","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.canlet.2016.03.020","article-title":"(64)Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133(+) cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite","volume":"376","author":"Yoshii","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.radonc.2025.111325_b0100","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.nucmedbio.2016.07.007","article-title":"Efficient preparation of high-quality (64)Cu for routine use","volume":"43","author":"Ohya","year":"2016","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.radonc.2025.111325_b0105","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1158\/0008-5472.CAN-08-3886","article-title":"Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors","volume":"69","author":"Wakimoto","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2025.111325_b0110","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1158\/1078-0432.CCR-18-4144","article-title":"PI3K\/AKT\/mTOR pathway alterations promote malignant progression and xenograft formation in oligodendroglial tumors","volume":"25","author":"Tateishi","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2025.111325_b0115","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1158\/1078-0432.CCR-21-3622","article-title":"HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant high-grade Glioma","volume":"28","author":"Sasame","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2025.111325_b0120","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1158\/1078-0432.CCR-13-3052","article-title":"Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas","volume":"20","author":"Wakimoto","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2025.111325_b0125","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2967\/jnumed.117.201632","article-title":"Comparative In vitro and in vivo quantifications of pathologic tau deposits and their association with neurodegeneration in tauopathy mouse models","volume":"59","author":"Ni","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2025.111325_b0130","doi-asserted-by":"crossref","first-page":"88815","DOI":"10.18632\/oncotarget.21323","article-title":"(64)Cu-ATSM internal radiotherapy to treat tumors with bevacizumab-induced vascular decrease and hypoxia in human colon carcinoma xenografts","volume":"8","author":"Yoshii","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2025.111325_b0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/neuonc\/not159","article-title":"IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection","volume":"16","author":"Beiko","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2025.111325_b0140","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamaoncol.2019.6143","article-title":"Association of maximal extent of resection of contrast-enhanced and non-contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed glioblastoma","volume":"6","author":"Molinaro","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2025.111325_b0145","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.30.9.907","article-title":"Assumptions in the radiotherapy of glioblastoma","volume":"30","author":"Hochberg","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.radonc.2025.111325_b0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-022-00621-0","article-title":"Advances in local therapy for glioblastoma - taking the fight to the tumour","author":"van Solinge","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.radonc.2025.111325_b0155","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.7150\/thno.56639","article-title":"A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma","volume":"11","author":"Bolcaen","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.radonc.2025.111325_b0160","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1586\/14737175.2015.1028369","article-title":"Focused ultrasound-mediated drug delivery through the blood-brain barrier","volume":"15","author":"Burgess","year":"2015","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.radonc.2025.111325_b0165","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2967\/jnumed.123.266205","article-title":"Theranostics in neurooncology: heading toward new horizons","volume":"65","author":"Tolboom","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2025.111325_b0170","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb4105","article-title":"PET, image-guided HDAC inhibition of pediatric diffuse midline glioma improves survival in murine models","volume":"6","author":"Tosi","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.radonc.2025.111325_b0175","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tranon.2017.10.006","article-title":"Multiple administrations of (64)Cu-ATSM as a novel therapeutic option for glioblastoma: a translational study using mice with xenografts","volume":"11","author":"Yoshii","year":"2018","journal-title":"Transl Oncol"},{"key":"10.1016\/j.radonc.2025.111325_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086996","article-title":"Controlled administration of penicillamine reduces radiation exposure in critical organs during (64)Cu-ATSM internal radiotherapy: a novel strategy for liver protection","volume":"9","author":"Yoshii","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2025.111325_b0185","doi-asserted-by":"crossref","first-page":"936","DOI":"10.2967\/jnumed.115.168906","article-title":"Intratumorally injected 177Lu-labeled gold nanoparticles: gold nanoseed brachytherapy with application for neoadjuvant treatment of locally advanced breast cancer","volume":"57","author":"Yook","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2025.111325_b0190","article-title":"Phase I clinical trial of 64Cu-ATSM for malignant brain tumors","author":"Kurihara","year":"2024","journal-title":"ASCO Annual Meeting"},{"key":"10.1016\/j.radonc.2025.111325_b0195","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1158\/1078-0432.CCR-23-1660","article-title":"Intraoperative integrated diagnostic system for malignant central nervous system tumors","volume":"30","author":"Hayashi","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2025.111325_b0200","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1038\/s41598-020-61056-5","article-title":"Immuno-OpenPET: a novel approach for early diagnosis and image-guided surgery for small resectable pancreatic cancer","volume":"10","author":"Yoshii","year":"2020","journal-title":"Sci Rep"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025053290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025053290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:25:58Z","timestamp":1786537558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025053290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":40,"alternative-id":["S0167814025053290"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111325","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local therapy with hypoxia-targeting radiopharmaceutical [64Cu]Cu-ATSM in high-grade glioma patient-derived xenograft models","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111325"}}